You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

~ Buy the ZEJULA (niraparib tosylate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR ZEJULA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Zejula

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03207347 ↗ A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001) Suspended GlaxoSmithKline Phase 2 2018-08-13 This open-label, non-randomized study will investigate the use of niraparib in patients with tumors known to have mutations in BAP1 and other select DNA damage response pathway genes.
NCT03207347 ↗ A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001) Suspended Tesaro, Inc. Phase 2 2018-08-13 This open-label, non-randomized study will investigate the use of niraparib in patients with tumors known to have mutations in BAP1 and other select DNA damage response pathway genes.
NCT03207347 ↗ A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001) Suspended University of Florida Phase 2 2018-08-13 This open-label, non-randomized study will investigate the use of niraparib in patients with tumors known to have mutations in BAP1 and other select DNA damage response pathway genes.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Zejula

Condition Name

Condition Name for Zejula
Intervention Trials
Ovarian Cancer 10
Neoplasms 6
Ovarian Neoplasms 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Zejula
Intervention Trials
Ovarian Neoplasms 16
Carcinoma, Ovarian Epithelial 14
Breast Neoplasms 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Zejula

Trials by Country

Trials by Country for Zejula
Location Trials
United States 152
Germany 8
China 8
Italy 7
United Kingdom 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Zejula
Location Trials
Massachusetts 13
California 12
Florida 10
North Carolina 8
New York 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Zejula

Clinical Trial Phase

Clinical Trial Phase for Zejula
Clinical Trial Phase Trials
Phase 3 4
Phase 2 37
Phase 1/Phase 2 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Zejula
Clinical Trial Phase Trials
Recruiting 24
Not yet recruiting 18
Active, not recruiting 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Zejula

Sponsor Name

Sponsor Name for Zejula
Sponsor Trials
Tesaro, Inc. 21
GlaxoSmithKline 20
Massachusetts General Hospital 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Zejula
Sponsor Trials
Other 81
Industry 63
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.